| XSpray specializes in optimizing the perform- ance of challenging drug substances – poorly soluble compounds, inhaled compounds and biomolecules.
A proprietary technology platform enables full control over particle design and production – simplifying drug formulation, extending delivery options and allowing the addition of innovative properties that truly benefit patients. The technology is ideally suited to the development of new chemical entities as well as drug reformulation and lifecycle management. |
|
